China Prescription Drug 2007 Issue 7 Diabetes Drugs under Scrutiny in a Post-Vioxx World

Diabetes Drugs under Scrutiny in a Post-Vioxx World
Emma Marris

..............page:59

Dispute over the Cardiovascular Safety of Rosiglitazone:an Unsettled Case
yang jin kui

..............page:57-58

Dispute over the Cardiovascular Safety of Rosiglitazone
li zuo ; zhou zhi guang

..............page:54-56

Speculation on the Cardiovascular Safety of Rosiglitazone
yu de min ; yu

..............page:50-53

"qing zuo su zhi fu " li guo qiao de yi feng xin
li guo qiao

..............page:37

Revised Provisional Rules for Drug Registration
liu peng

..............page:35-36

Zhu Li-hong :We are Doing Not Only a Single Work

..............page:34

Xie Yan-bin :Kendlewits Plays New Roles

..............page:33-34

Su Ling :Satisfaction from Being an Upright Person and Charitable Deeds

..............page:32-33

Zhao Jian :Enjoy Dedication

..............page:32

Kaleidoscope——High-ranking Dialogue on Clinical Trial in China Act Ⅲ:Infantile Public Opinion?
zhong guo chu fang yao bian ji bu

..............page:30-31

Kaleidoscope——High-ranking Dialogue on Clinical Trial in China Act Ⅱ The Elephant and the Dragon :The Rise of India and China in Clinical Trial
zhong guo chu fang yao bian ji bu

..............page:29-30

Kaleidoscope——High-ranking Dialogue on Clinical Trial in China Act Ⅰ :Go East
zhong guo chu fang yao bian ji bu

..............page:25-28

Rosiglitazone and Cardiotoxity——Weighing the Evidence
David M.Nathan

..............page:60-61

Avandia,to be or not to be
yu li

..............page:62-63

xue shu shi ye : luo ge lie tong de xin xue guan an quan xing 1

..............page:64-65

Study,Enlightenment,and Solution——Periscopical Review of Drug Advertising Management System
song hua lin

..............page:38

Going Favorable——Looking into the Drug Advertising Management Regulation and the Some Speculations
ma ying juan

..............page:39-40

From Separated Approval and Surveillance to Integrated Management——Speculation on Reform of Drug Advertising Management
tang ming liang

..............page:41-42

FDA and FTC Dispute over Advertising Regulation
zuo gen yong

..............page:43-44

Teratogenicity of SSRIs-Serious Concern or Much Ado about Little?
michael f.greene; qiu yu

..............page:7

Back to the future for Chinese herbal medicine
zhou zuo

..............page:8

Drug-resistant TB :Should be Worried?
jillene magill-lewis; liang wei

..............page:9

bei huan xing de feng xian yi shi guang dong yao shi yu zhuan jia xue zhe zai zhu ti wei " yao shi zhi ye feng xian ji gui bi " de di er jie zhong guo yao shi lun tan shang hu dong ji lie
mao dong lei ; huang jin

..............page:18-20

guan zhu zui xin dong tai liao jie xue ke jin zhan hua nan zu zhong zhen zhi xin jin zhan yan tao hui ri qian zai dong zuo zhao kai
yu li

..............page:20

ya zhou yao xue mei hao ming tian ji " di qi jie ya zhou lin chuang yao xue da hui "
lu dong hu

..............page:21

Shrinking and Expansion of Hospital Function——before and after the High Renaissance
wei jing fa

..............page:46-47

Decision-making in Evidence-based Medicine
tai cu

..............page:48-49

yao pin zhi liang yu an quan ze ren
tan yong

..............page:76

cong ji chu zou xiang lin chuang guo ji xin zang yan jiu hui di shi jiu jie shi jie da hui jian jie
yu xi yong

..............page:66-68

tang niao bing yong yao shi chang : xi yao zhan jue dui you shi
zong yun gang

..............page:70-71

pu tao qiu jun xing tang shang yang pi fu zong he zheng 19 li lin chuang fen xi
he de zhu ; duan zhen zhong ; dong ying hao ; li chao qun

..............page:69

wan ru fan hua zai shun jian zhan fang
yang tian

..............page:2

lai xin

..............page:5-6

xin shi

..............page:12-13

sheng yin shu zi

..............page:14

xin yao gong gao lan

..............page:15-16

adr feng xiang biao

..............page:17

cui chan su shou ti zuo kang ji zhi liao zao chan 1 li
wang zhen hua ; zhang jian ping

..............page:72-73

ying yong yi yuan chu fang fen xi fen xi ma zui yao pin de yong yao he li xing
li rui zhen ; chen fei yuan ; liu jie

..............page:74-75

Picture This

..............page:10-11

tou gao xu zhi

..............page:73

you yao wu lin chuang shi yan ji qi ta
mao dong lei

..............page:22

Chinese Expression in the 43rd DIA Annual Meeting
li xing

..............page:23-24